Read the latest and past features

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are often recommended as first-line treatments to ease pain, stiffness, and joint inflammation in mild psoriatic arthritis (PsA).

March is Autoimmune Awareness Month. This year, PAPAA is joining our Connect Immune Research partners to highlight the impact of autoimmune conditions and the importance of working together to improve understanding, treatment and support.

PAPAA is marking Rare Disease Day today, 28 February, by shining a light on the lesser-known but serious forms of psoriatic disease that affect people and families worldwide.

In our recent feature, Dry January: A simple reset for people with psoriatic disease, we explored how taking a break from alcohol can ease pressure on your liver, support your medicines and reduce a known trigger for some people.

Young adults aged 18-35 living with psoriasis or psoriatic arthritis: your voice can transform global awareness.

The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year agreement to bolster WHO's efforts in enhancing global understanding, diagnosis, and care for psoriasis.

Research shows that people with psoriasis and psoriatic arthritis can have a higher risk of heart disease and stroke because of ongoing inflammation and other related health factors.

The 10‑Year Health Plan recognises that the NHS cannot deliver this transformation alone and must work closely with the voluntary sector, life sciences and technology partners.

The personal stories shared on PAPAA's engagement section reveal raw realities, from a fierce itch that no amount of scratching eases, to skin covering the entire body in inflamed, cracked patches.

Psoriatic arthritis (PsA) is one of those conditions that can be very familiar to some people and completely new to others.